Steven Roser, DMD
Oral and Maxillofacial Surgery · Atlanta, GANPI 1235143389
Payments from drug & device makers
What this record shows
The money is spread across several categories — charitable contributions (51.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Eagle Pharmaceuticals, Inc. at 51.1% of the total. Reporting peaked in 2020 at $5,640 and has fallen 64.8% since, to $1,987 in 2025. Among oral and maxillofacial surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $367.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eagle Pharmaceuticals, Inc.$6K
- Kls-martin L.p.$3K
- Stryker$1K
- Synthes GmbH$1K
- Medline Industries LP$194
- Geistlich Pharma, North America, Inc.$50
- plus $20 from 1 others
What the payments were for
- Speaking & faculty fees$1,0009%
- Travel & lodging$1,78416%
- Food & beverage$2,61324%
- Charitable contribution$5,64051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eagle Pharmaceuticals, Inc. | 1 | $5,640 |
| Kls-martin L.p. | 13 | $2,556 |
| Stryker | 11 | $1,427 |
| Synthes GmbH | 2 | $1,149 |
| Medline Industries LP | 1 | $194 |
| Geistlich Pharma, North America, Inc. | 1 | $50 |
| Axogen | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,038 in reported general payments places this provider in the 90th percentile of 236 oral and maxillofacial surgery providers in Georgia.
See all oral and maxillofacial surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 148 | $4,410 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 67 | $2,713 |
| Chlorhexidine Gluconate | 362 | $1,511 |
| Amoxicillin | 166 | $644 |
| Dexamethasone | 11 | $556 |
| Ibuprofen | 94 | $313 |
| Oxycodone Hcl | 83 | $148 |
| Clindamycin Hcl | 17 | $145 |
| Baclofen | 11 | $85 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $54 |
| Tramadol Hcl | 16 | $24 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Atlanta
- Dina AminAtlanta$21K
- Gary BoulouxAtlanta$12K
- Thomas BerryAtlanta$5K
- Stephanie DrewAtlanta$4K
- Hari DigumarthiAtlanta$3K
- Salam SalmanCalhoun$60K
- Jay ReznickWoodstock$51K
- Paul SchanerMarietta$42K
- Ryan SemensohnBrookhaven$39K
- Raymond DickeyDallas$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.